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KEYWORDS
Oropharyngitis;
Fusobacterium
necrophorum
Summary  The  last  ﬁfteen  years  have  witnessed  a  remarkable  increase  in  the
reported  cases  of  Lemierre’s  Syndrome  (LS),  which  was  once  called  the  forgotten
disease.  LS  manifests  as  oropharyngitis  and  a  blood  stream  infection  with  Fusobac-
terium  necrophorum  and  internal  jugular  vein  thrombosis.  LS  is  a  challenge  for
clinicians,  as  it  is  often  difﬁcult  to  diagnose  and  is  associated  with  signiﬁcant  mor-
bidity.  In  recognition  of  the  importance  of  raising  the  awareness  about  rare  diseases,
herein,  we  describe  a  case  of  LS  in  a  21-year-old  male  that  was  treated  successfully
after  two  weeks  of  hospitalization;  we  have  also  included  a  brief  literature  review.
©  2016  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.
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tase Presentation
 previously  healthy  21-year-old  male  presented
o the  Emergency  Department  (ED)  complaining  of
eneralized  fatigue,  fever,  and  a  sore  throat  last-
ng for  3  days.  The  patient  was  admitted  to  the
D 3  days  prior  for  the  same  complaint,  at  which
ime he  had  a  negative  rapid  strep  A  test  and
as discharged  home  after  receiving  IV  hydration.
t the  second  visit,  his  temperature  was  38,  his
eart rate  was  144  and  his  blood  pressure  was
50/83. The  positive  ﬁndings  on  his  physical  exam
ncluded  pharyngeal  erythema,  submandibular  lym-
hadenopathy  and  splenomegaly.  The  initial  labs
howed a  high  neutrophil  count  of  92.6%,  an  ele-
ated CRP  of  298.2,  and  a  raised  creatinine  of  1.39.
he Monotest  and  EBV  IgG  test  were  both  positive.
e was  admitted  to  the  hospital  and  was  started
n symptomatic  treatment  for  infectious  mononu-
leosis.  His  condition  continued  to  deteriorate
p
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a
ttp://dx.doi.org/10.1016/j.jiph.2016.01.006
876-0341/© 2016 King Saud Bin Abdulaziz University for Health Scies  he  became  more  febrile  and  tachypneic,  and
e was  subsequently  transferred  to  the  Inten-
ive Care  Unit  (ICU).  Administration  of  empiric
road spectrum  IV  antibiotics  was  started,  and  the
atient was  placed  on  BiPAP.  Chest  CT  revealed
umerous bilateral,  predominantly  pleural-based,
odular opacities  with  a mixture  of  ground  glass  and
arly cavitations  (Fig.  1).
The blood  culture  was  positive  for  Fusobac-
erium necrophorum,  which  raised  the  suspicion
f Lemierre’s  Syndrome.  Neck  CT  showed  throm-
ophlebitis of  both  the  right  supraclavicular  and
ight external  jugular  veins,  which  conﬁrmed  the
iagnosis  (Fig.  2).
The  hospital  course  was  complicated  by  a  recur-
ent large  left-sided  pleural  effusion  that  was
apped twice  with  no  evidence  of  an  empyema.  The
atient  showed  gradual  improvement  and  was  dis-
harged home  on  a  two-week  course  of  Augmentin
fter 14  days  of  hospitalization.
nces. Published by Elsevier Limited. All rights reserved.
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Figure  1  An  axial  slice  of  a  chest  CT  shows  bilateral
nodular  opacities  (arrows)  concerning  for  septic  emoboli.
Figure  2  An  axial  slice  of  a  Neck  CT  shows  stranding
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Fundinginﬂammatory  changes  along  the  course  of  the  right  exter-
nal  jugular  vein  which  appears  thrombosed  (arrow).
Discussion
Lemierre’s  Syndrome  (LS)  manifests  as  an  orop-
haryngeal infection  of  bacteremia  with  Fusobac-
terium necrophorum  and  internal  jugular  vein
thrombosis.
LS was  ﬁrst  described  by  Andre  Lemierre  [1];
however, it  was  not  until  1980  that  Vogel  and  Boyer
deﬁned  a  syndrome  that  they  named  Lemierre’s
postanginal septicemia  using  the  abovementioned
trilogy of  signs  [2].  In  1983,  Shannon  et  al.  was  the
ﬁrst author  to  refer  to  this  syndrome  as  LS  [3].
LS was  once  called  the  forgotten  disease  due
to the  remarkable  drop  in  published  reports  of
this infection;  however,  there  has  since  been  a
remarkable  increase  in  the  number  of  reported
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ases  and  possibly  the  actual  incidence  of  the  dis-
ase. A  search  of  PubMed  using  the  term  Lemierre’s
yndrome as  the  only  key  word  reveals  43  arti-
les published  between  1980  and  1995  and  376
rticles  published  between  1996  and  2011.  It has
een suggested  that  this  increase  could  be  due
o the  current  usage  of  antibiotics  causing  more
erious  F.  necrophorum  infections  [4]. Multiple  sur-
eys/studies  in  the  USA,  Canada  and  Australia  have
hown a signiﬁcant  decline  in  the  prescription  of
ntibiotics  for  upper  respiratory  infections  in  the
ate 1990s  and  early  2000s  compared  to  the  late
980s and  early  1990s  [5—8].
In a systematic  review  of  114  cases,  the  median
ge of  LS  patients  was  22  years,  and  the  most  com-
on presenting  symptom  (33%  of  the  patients)  was
ore throat.  F. necrophorum  was  the  most  common
ausative organism  (57%  of  the  patients),  and  CXR
as the  most  commonly  ordered  test  followed  by
eck/chest  CT  (92%  and  55%  of  cases,  respectively).
he median  hospital  stay  duration  was  25  days,  and
ore than  50%  of  patients  required  treatment  at
he ICU  [9].
A  beta-lactamase  resistant  antibiotic  should  be
sed to  treat  LS.  According  to  Armstrong  et  al.,
etronidazole  is  the  most  commonly  prescribed
gent [10].  In  one  study,  resistance  to  penicillin  was
eported in  2%  of  208  LS  patients  [11]. The  role  of
nticoagulation  in  LS  is  still  unclear  [12].
onclusion
e  believe  that  it  is  essential  to  continue  to  raise
wareness  of  LS  in  the  medical  society.  It  is a  rare
isease  with  a  very  common  presenting  symptom,
hich makes  its  diagnosis  a challenge  for  clinicians.
he signiﬁcant  morbidity  associated  with  LS  should
rompt  collaboration  between  multiple  specialists
o arrive  at better  outcomes  and  shorter  hospital
tays.
It is difﬁcult  to  determine  whether  the  recent
ise in  reported  cases  of  LS  is  due  to  an  actual
ncrease in  the  incidence  of  this  disease  resulting
rom the  continuous  decline  in  the  prescription  of
ntibiotics  or  is  simply  due  to  an  increase  in  the
umber of  published  cases.  Nevertheless,  the  tem-
oral association  between  the  increase  in  LS  and
ecrease  in  antibiotics  usage  found  in  the  literature
s intriguing  and  is  deﬁnitely  worth  further  study.o  funding  sources.
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